SEC Filing Details
Document Details
Form
Filing Date
Dec 20, 2022
Document Date
Dec 20, 2022
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
BioLineRx
Issuer
BioLineRx Ltd.
Press Releases View all
January 4, 2023
BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
December 20, 2022
November 28, 2022
BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event